The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Accumulation of hydrogen peroxide is an early and crucial step for paclitaxel‐induced cancer cell death both in vitro and in vivo
Open accessAbstract
Intracellular events following paclitaxel binding to microtubules that lead to cell death remain poorly understood. Because reactive oxygen species (ROS) are involved in the cytotoxicity of anticancer agents acting through independent molecular targets, we explored the role of ROS in paclitaxel cytotoxicity. Within 15 min after in vitro exposure of A549 human lung cancer cells to paclitaxel, a concentration‐dependent intracellular increase in O°2− and H 2 O 2 levels was detected by spectrofluorometry. Addition of N‐acetylcysteine (NAC) or glutathione, two H 2 O 2 scavenger, induced a 4‐fold increase in paclitaxel IC 50. Delaying NAC co‐incubation by 4 hr, resulted in a 3‐fold reduction in cell protection. The glutathione synthesis inhibitor, buthionine sulfoximine significantly increased paclitaxel cytotoxicity and H 2 O 2 accumulation, but did not modify O°2− levels. Co‐incubation with diphenylene iodonium suggested that paclitaxel induced‐O°2− production was in part associated with increased activity of cytoplasmic NADPH oxidase. Concomitant treatment with inhibitors of caspases 3 and 8 increased cell survival but did not prevent the early accumulation of H 2 O 2. To evaluate the role of ROS in paclitaxel antitumoral activity, mice were injected with LLC1 lung cancer cells and treated with paclitaxel i.p. and/or NAC. The antitumoral activity of paclitaxel in mice was abolished by NAC. In conclusion, the accumulation of H 2 O 2 is an early and crucial step for paclitaxel‐induced cancer cell death before the commitment of the cells into apoptosis. These results suggest that ROS participate in vitro and in vivo to paclitaxel cytotoxicity. © 2006 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Taxol stabilizes microtubules in mouse fibroblast cells.
Schiff, P. B., & Horwitz, S. B. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.3.1561 · Cited by 1,970
Aruoma, O. I., Halliwell, B., Hoey, B. M., & Butler, J. (1989) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(89)90066-x · Cited by 1,772
Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations.
Jordan, M. A., Toso, R. J., Thrower, D., & Wilson, L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.20.9552 · Cited by 1,095
Mitochondria, oxygen free radicals, disease and ageing
Raha, S., & Robinson, B. H. (2000) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)01674-1 · Cited by 1,066 · cited 1×
“H2O2 is in part converted into H2O by GSH–peroxidase that uses GSH as coenzyme.(27) Since GSH depletion has not been observed during the”
MethodSurvival signalling by Akt and eIF4E in oncogenesis and cancer therapy
Wendel, H.-G., Stanchina, E. D., Fridman, J. S., Malina, A., Ray, S., Kogan, S., Cordon-Cardo, C., Pelletier, J., & Lowe, S. W. (2004) · Nature · doi:10.1038/nature02369 · Cited by 951
Jordan, M. A., Wendell, K., Gardiner, S., Derry, W. B., Copp, H., & Wilson, L. (1996) · PubMed · Cited by 770
Mechanisms of Taxol resistance related to microtubules
Orr, G. A., Verdier-Pinard, P., McDaid, H., & Horwitz, S. B. (2003) · Oncogene · doi:10.1038/sj.onc.1206934 · Cited by 727
Babior, B. M. (2004) · Current Opinion in Immunology · doi:10.1016/j.coi.2003.12.001 · Cited by 705
ROS, stress‐activated kinases and stress signaling in cancer
Benhar, M., Engelberg, D., & Levitzki, A. (2002) · The EMBO Reports · doi:10.1093/embo-reports/kvf094 · Cited by 600
Differential Modulation of Apoptosis Sensitivity in CD95 Type I and Type II Cells
Scaffidi, C., Schmitz, I., Zha, J., Korsmeyer, S. J., Krammer, P. H., & Peter, M. E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.32.22532 · Cited by 580
Dai, J., Weinberg, R. S., Waxman, S., & Jing, Y. (1999) · Blood · doi:10.1182/blood.v93.1.268 · Cited by 540
Controlling Tumor Growth by Modulating Endogenous Production of Reactive Oxygen Species
Laurent, A., Nicco, C., Chéreau, C., Goulvestre, C., Alexandre, J., Alves, A., Lévy, E., Goldwasser, F., Panis, Y., Soubrane, O., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.948.65.3 · Cited by 509
Self-citationDisruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifylline.
Fan, S., Smith, M. L., Rivet, D. J., Duba, D. E., Zhan, Q., Kohn, K. W., Fornace, A. J., & O'Connor, P. M. (1995) · PubMed · Cited by 490
(2003) · PubMed · Cited by 465
Hwang, P. M., Bunz, F., Yu, J., Rago, C., Chan, T. A., Murphy, M. P., Kelso, G. F., Smith, R. A. J., Kinzler, K. W., & Vogelstein, B. (2001) · Nature Medicine · doi:10.1038/nm1001-1111 · Cited by 422
Mechanisms of Taxol-induced cell death are concentration dependent.
Torres, K. E., & Horwitz, S. B. (1998) · PubMed · Cited by 385
Idziorek, T., Estaquier, J., De Bels, F., & Ameisen, J.-C. (1995) · Journal of Immunological Methods · doi:10.1016/0022-1759(95)00172-7 · Cited by 381
Inhibition of p21‐mediated ROS accumulation can rescue p21‐induced senescence
Macip, S., Igarashi, M., Fang, L., Chen, A., Pan, Z., Lee, S. W., & Aaronson, S. A. (2002) · The EMBO Journal · doi:10.1093/emboj/21.9.2180 · Cited by 374
Wang, T.-H., Wang, H.-S., Ichijo, H., Giannakakou, P., Foster, J. S., Fojo, T., & Wimalasena, J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.9.4928 · Cited by 353
De Flora, S., Izzotti, A., D'Agostini, F., & Balansky, R. M. (2001) · Carcinogenesis · doi:10.1093/carcin/22.7.999 · Cited by 351
Influence of Induced Reactive Oxygen Species in p53-Mediated Cell Fate Decisions
Macip, S., Igarashi, M., Berggren, P., Yu, J., Lee, S. W., & Aaronson, S. A. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.23.8576-8585.2003 · Cited by 331
Prediction of Docetaxel Response in Human Breast Cancer by Gene Expression Profiling
Iwao-Koizumi, K., Matoba, R., Ueno, N., Kim, S. J., Ando, A., Miyoshi, Y., Maeda, E., Noguchi, S., & Kato, K. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.09.078 · Cited by 309
Huizing, M. T., Keung, A. C., Rosing, H., van der Kuij, V, ten Bokkel Huinink, W. W., Mandjes, I. M., Dubbelman, A. C., Pinedo, H. M., & Beijnen, J. H. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.11.2127 · Cited by 308
Benhar, M., Dalyot, I., Engelberg, D., & Levitzki, A. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.20.6913-6926.2001 · Cited by 306
Carreá, M., Andreá, N., Carles, G., Borghi, H., Brichese, L., Briand, C., & Braguer, D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203834200 · Cited by 273
Simizu, S., Takada, M., Umezawa, K., & Imoto, M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.41.26900 · Cited by 263
Rice, G. C., Bump, E. A., Shrieve, D. C., Lee, W., & Kovacs, M. S. (1986) · PubMed · Cited by 245
Wang, T.-H., Popp, D. M., Wang, H.-S., Saitoh, M., Mural, J. G., Henley, D. C., Ichijo, H., & Wimalasena, J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.8208 · Cited by 216
Differential mitotic responses to microtubule-stabilizing and -destabilizing drugs.
Chen, J.-G., & Horwitz, S. B. (2002) · PubMed · Cited by 212
Liu, G., & Chen, X. (2002) · Oncogene · doi:10.1038/sj.onc.1205862 · Cited by 207
Sasada, T., Iwata, S., Sato, N., Kitaoka, Y., Hirota, K., Nakamura, K., Nishiyama, A., Taniguchi, Y., Takabayashi, A., & Yodoi, J. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118668 · Cited by 201
Taxol Induces Caspase-10-dependent Apoptosis
Park, S.-J., Wu, C.-H., Gordon, J. D., Zhong, X., Emami, A., & Safa, A. R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406543200 · Cited by 198
André, N., Braguer, D., Brasseur, G., Gonçalvès, A., Lemesle-Meunier, D., Guise, S., Jordan, M. A., & Briand, C. M. (2000) · PubMed · Cited by 178
von Haefen, C., Wieder, T., Essmann, F., Schulze-Osthoff, K., Dörken, B., & Daniel, P. T. (2003) · Oncogene · doi:10.1038/sj.onc.1206280 · Cited by 177
Inhibition of glutathione synthesis reverses Bcl-2-mediated cisplatin resistance.
Rudin, C. M., Yang, Z., Schumaker, L. M., VanderWeele, D. J., Newkirk, K. A., Egorin, M. J., Zuhowski, E. G., & Cullen, K. J. (2003) · PubMed · Cited by 174
Taxol and discodermolide represent a synergistic drug combination in human carcinoma cell lines.
Martello, L. A., McDaid, H. M., Regl, D. L., Yang, C. P., Meng, D., Pettus, T. R. R., Kaufman, M. D., Arimoto, H., Danishefsky, S. J., Smith, A. B., et al. (2000) · PubMed · Cited by 166
DNA-damaging reagents induce apoptosis through reactive oxygen species-dependent Fas aggregation
Huang, H.-L., Fang, L., Lu, S.-P., Chou, C., Luh, T., & Lai, M. (2003) · Oncogene · doi:10.1038/sj.onc.1206979 · Cited by 156
Goldwasser, F., Shimizu, T., Jackman, J., Hoki, Y., O'Connor, P. M., Kohn, K. W., & Pommier, Y. G. (1996) · PubMed · Cited by 134
Self-citationPaclitaxel targets mitochondria upstream of caspase activation in intact human neuroblastoma cells
André, N., Carré, M., Brasseur, G., Pourroy, B., Kovacic, H., Briand, C. M., & Braguer, D. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03691-8 · Cited by 133
Albini, A., D’Agostini, F., Giunciuglio, D., Paglieri, I., Balansky, R. M., & Flora, S. D. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910610121 · Cited by 120
Diebold, B. A., Fowler, B. J., Lu, J., Dinauer, M. C., & Bokoch, G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313891200 · Cited by 96
Shiah, S., Chuang, S. E., Chau, Y., Sj, S., & Kuo, M. (1999) · PubMed · Cited by 94
Gonçalvès, A., Braguer, D., Carles, G., et al. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00481-0 · Cited by 91
Amato, S. F., Swart, J. M., Berg, M., Wanebo, H. J., Mehta, S. R., & Chiles, T. C. (1998) · PubMed · Cited by 90
Modulation of biomarkers by chemopreventive agents in smoke-exposed rats.
Izzotti, A., Balansky, R. M., D’Agostini, F., Bennicelli, C., Myers, S. R., Grubbs, C. J., Lubet, R. A., Kelloff, G. J., & Flora, S. D. (2001) · PubMed · Cited by 83
Flora, S. D., Agostini, F. D., Masiello, L., Giunciuglio, D., & Albini, A. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960917)67:6<842::aid-ijc14>3.0.co;2-3 · Cited by 64
Jung, M.-S., Jin, D.-H., Chae, H., Kang, S., Kim, S., Bang, Y., Choi, T.-S., Choi, K. S., & Shin, D. Y. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m305015200 · Cited by 62
Microtubule Integrity Regulates Pak Leading to Ras-independent Activation of Raf-1
Zang, M., Waelde, C. A., Xiang, X., Rana, A., Wen, R., & Luo, Z. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100152200 · Cited by 48
Shellard, S. A., Hosking, L. K., & Hill, B. T. (1991) · PubMed · Cited by 44
N-Acetylcysteine for Lung Cancer Prevention
van Zandwijk, N. (1995) · CHEST Journal · doi:10.1378/chest.107.5.1437 · Cited by 36
Cited by
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
Trachootham, D., Alexandre, J., & Huang, P. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2803 · Cited by 5,452
Self-citationReactive oxygen species in cancer
Liou, G.-Y., & Storz, P. (2010) · Free Radical Research · doi:10.3109/10715761003667554 · Cited by 3,382
Oxidative stress and cancer: Have we moved forward?
Halliwell, B. (2007) · Biochemical Journal · doi:10.1042/bj20061131 · Cited by 1,302
Role of Reactive Oxygen Species in Cancer Progression: Molecular Mechanisms and Recent Advancements
Aggarwal, V., Tuli, H., Varol, A., Thakral, F., Yerer, M., Sak, K., Varol, M., Jain, A., Khan, M., & Sethi, G. (2019) · Biomolecules · doi:10.3390/biom9110735 · Cited by 1,221
Elevated copper and oxidative stress in cancer cells as a target for cancer treatment
Gupte, A., & Mumper, R. J. (2009) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2008.07.004 · Cited by 1,036
Metadata
- Authors
- Alexandre, J., Batteux, F., Nicco, C., Chéreau, C., Laurent, A., Guillevin, L., Weill, B., & Goldwasser, F.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2006-04-17
- Volume
- 119
- Issue
- 1
- Pages
- 41-48
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2021568546
- Cited by
- 310
- References
- 50
- FWCI
- 6.38
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.